Fibplant

Genetically Engineered Fibrin Sealant

Active Pre-Seed Startup Tel Aviv-Yafo Founded 2019-05

Fibplant is developing a genetically engineered Fibrinogen, intended to be uses as a biological glue for an existing pharma drug market. The company's advanced active compositions are based on therapeutic proteins produced in transgenic plants, and made for Surgery and Emergency medicine.

SectorHealth Tech & Life Sciences
StagePre-Seed
Employees3
Founded2019-05
HQTel Aviv-Yafo
Confidence80
Sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technology
BiologicalsHerbals
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals